Although the mechanisms of anticancer effects via CDK7 inhibition have been associated with cell cycle arrest and apoptosis in various cancers [16,46,47], until recently, biomarkers for determining the sensitivity of cells to CDK7 inhibitors have been unclear. This evidence concerns the gene CDK7 and cancer.